Aerovate Therapeutics, Inc. - COM (AVTE)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM
Number of holders
60
Total Shares
28.5M
Shares change
+2.49M
Total reported value, excl. options
$488M
Value change
+$39.1M
Put/Call ratio
0
Number of buys
27
Number of sells
-22
Price
$17.15
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.